Platelet-free plasma from schizophrenic patients satisfying research diagnostic criteria for chronic schizophrenia was obtained and mixed with platelet-rich plasma from normal controls. Decreases in control platelet monoamine oxidase activity were observed, with some control platelets apparently much more sensitive than others to the inhibitory activity of the chronic schizophrenic plasma. Experimental conditions and selection from sensitive control individuals seem crucial in demonstrating the presence of endogenous inhibitors in schizophrenics' plasma.
We reported in 1978 that platelet-free plasma obtained from chronic schizophrenic patients with low monoamine oxidase (MAO) activity, when mixed with platelets obtained from healthy individuals, could decrease platelet MAO activity (Berrettini and Vogel 1978) . This decrease did not seem to be caused by the experimental conditions employed, since control platelet-free plasma had no effect on platelet MAO activity (Berrettini and Vogel 1978) , or by antipsychotic medication since these drugs have been reported not to affect MAO activity (Murphy, Belmaker, and Wyatt 1974; Wyatt and Murphy 1976) . We postulated that chronic schizophrenic plasma contains an endogenous inhibitor of MAO.
After publication of this finding, two articles appeared; one article reported no effect of chronic schizophrenic plasma on MAO activity in most, but not all, cases (Wise et al. 1979 ) and one showed a general stimulation of enzyme activity after mixing (Yu and Boulton 1979) . In our opinion, observed discrepancies are probably caused by diffarent experimental conditions and selection of patients and controls. For this reason, we studied these parameters in more detail.
Methods and Materials
The patients selected for this study satisfied Research Diagnostic Criteria for chronic schizophrenia (Spitzer, Endicott, and Robins 1975) , and all had low platelet MAO activity. The control population was selected from healthy staff and laboratory personnel.
Approximately 40 ml of whole blood was drawn, from both patients and controls, into 15 ml evacuated glass tubes which contained 0.3 ml of 5 percent EDTA. Whole blood was centrifuged at 350g for 30 minutes to obtain platelet-rich plasma. An aliquot of this plasma was spun for 20 minutes at l,100g to form a platelet plug. To obtain platelet-free plasma, the above plasma was spun again for 20 minutes at l,100g. The platelet-rich plasma from the control individual was mixed with the platelet-free plasma from the schizophrenic in 1:1 and 1:3 ratios. The details of the enzyme assay have been previously described (Berrettini and Vogel 1978) .
Maximal velocity (V max ) and the Michaelis constant (Km) were obtained by an Eadie Hofstee plot and the best line of the plot was determined by linear regression. only five out of eight experiments whereas a ratio of 1:3 produces a decrease in all eight experiments. Similarly, a decrease in K m becomes significant only at the 1:3 mixing ratio.. Thus, to uniformly demonstrate a : decrease in MAO activity a ratio of at least 1:3 seems necessary.
Results and Discussion
During our studies, we also noticed that some control platelets responded better than others to the inhibitory effects of chronic schizophrenic plasma. Table 2 shows the results of mixing the platelet-free plasma of two chronic schizophrenic patients with different control platelets. As can be seen, control MAO activity is affected differently, ranging from a 14 to 48 percent decrease in the first series of experiments and from no decrease (or a 5 percent stimulation) to a 35 percent reduction in the second series. Thus, not all control platelets seem to respond uniformly, and some control platelets seem to be more sensitive than others to the inhibitory activity of the chronic schizophrenic plasma.
In conclusion, experimental conditions and selection of control individuals seem to be highly critical in the demonstration of the endogenous inhibitor present in the plasma of chronic schizophrenic patients.
